Mitochondrial redox control of matrix metalloproteinases

Free Radical Biology and Medicine

Volumn 37, Issue 6, 2004, Pages 768-784

  Nelson, Kristin K ^a   Melendez, J Andres ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

activating protein 1; AP 1; Cancer; E twenty six; ECM; ERK; Ets; extracellular matrix; extracellular regulated kinase; Free radicals; Hydrogen peroxide; IL 1; interleukin 1; JNK; Matrix metalloproteinases; Reactive oxygen species; Superoxide dismutase

Indexed keywords

ANTIOXIDANT; GELATINASE A; HYDROGEN PEROXIDE; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN C JUN; PROTEIN FOS; RAS PROTEIN; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; S6 KINASE; STRESS ACTIVATED PROTEIN KINASE; STROMELYSIN; SUPEROXIDE DISMUTASE; SYNAPTOPHYSIN;

AGING; ARTHRITIS; ATHEROSCLEROSIS; CANCER; CATALYSIS; DEGENERATIVE DISEASE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; GENE EXPRESSION; HUMAN; ISCHEMIA; MITOCHONDRION; NERVE DEGENERATION; NONHUMAN; OXIDATION REDUCTION REACTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION;

AGING; ANIMALS; ANTIOXIDANTS; CONNECTIVE TISSUE; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; LIGHT; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASES; MITOCHONDRIA; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; NEOPLASMS; NEURODEGENERATIVE DISEASES; OXIDATION-REDUCTION; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; REPERFUSION INJURY; SIGNAL TRANSDUCTION; SKIN; SUPEROXIDE DISMUTASE;

EID: 4043161974     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2004.06.008     Document Type: Review

References (195)

1. Aikawa R., Komuro I., Yamazaki T., Zou Y., Kudoh S., Tanaka M., Shiojima I., Hiroi Y., Yazaki Y. Oxidative stress activates extracellular signal-regulated kinases through Src and Ras in cultured cardiac myocytes of neonatal rats. J. Clin. Invest. 100:1997;1813-1821
2. Arnold R.S., Shi J., Murad E., Whalen A.M., Sun C.Q., Polavarapu R., Parthasarathy S., Petros J.A., Lambeth J.D. Hydrogen peroxide mediates the cell growth and transformation caused by the mitogenic oxidase Nox1. Proc. Natl. Acad. Sci. USA. 98:2001;5550-5555
3. Dalton T.P., Shertzer H.G., Puga A. Regulation of gene expression by reactive oxygen. Annu. Rev. Pharmacol. Toxicol. 39:1999;67-101
4. Finkel T., Holbrook N.J. Oxidants, oxidative stress and the biology of ageing. Nature. 408:2000;239-247
5. 2) increases the steady-state mRNA levels of collagenase/MMP-1 in human dermal fibroblasts. Free Radic. Biol. Med. 22:1997;515-524
6. Clerk A., Michael A., Sugden P.H. Stimulation of multiple mitogen-activated protein kinase sub-families by oxidative stress and phosphorylation of the small heat shock protein, HSP25/27, in neonatal ventricular myocytes. Biochem. J. 333(Pt 3):1998;581-589
7. Xu Y., Kiningham K.K., Devalaraja M.N., Yeh C.C., Majima H., Kasarskis E.J., St Clair D.K. An intronic NF-kappaB element is essential for induction of the human manganese superoxide dismutase gene by tumor necrosis factor-alpha and interleukin-1beta. DNA Cell Biol. 18:1999;709-722
8. Kim K.H., Rodriguez A.M., Carrico P.M., Melendez J.A. Potential mechanisms for the inhibition of tumor cell growth by manganese superoxide dismutase. Antioxid. Redox Signal. 3:2001;361-373
9. Finkel T. Reactive oxygen species and signal transduction. IUBMB Life. 52:2001;3-6
10. Xu D., Rovira I.I., Finkel T. Oxidants painting the cysteine chapel: redox regulation of PTPs. Dev. Cell. 2:2002;251-252
11. Westermarck J., Li S.P., Kallunki T., Han J., Kahari V.M. p38 mitogen-activated protein kinase-dependent activation of protein phosphatases 1 and 2A inhibits MEK1 and MEK2 activity and collagenase 1 (MMP-1) gene expression. Mol. Cell Biol. 21:2001;2373-2383
12. Hoegy S.E., Oh H.R., Corcoran M.L., Stetler-Stevenson W.G. Tissue inhibitor of metalloproteinases-2 (TIMP-2) suppresses TKR-growth factor signaling independent of metalloproteinase inhibition. J. Biol. Chem. 276:2001;3203-3214
13. Bogumil R., Namgaladze D., Schaarschmidt D., Schmachtel T., Hellstern S., Mutzel R., Ullrich V. Inactivation of calcineurin by hydrogen peroxide and phenylarsine oxide: evidence for a dithiol-disulfide equilibrium and implications for redox regulation. Eur. J. Biochem. 267:2000;1407-1415
14. Yang J.Q., Zhao W., Duan H., Robbins M.E., Buettner G.R., Oberley L.W., Domann F.E. v-Ha-RaS oncogene upregulates the 92-kDa type IV collagenase (MMP-9) gene by increasing cellular superoxide production and activating NF-κB. Free Radic. Biol. Med. 31:2001;520-529
15. Lander H.M., Hajjar D.P., Hempstead B.L., Mirza U.A., Chait B.T., Campbell S., Quilliam L.A. A molecular redox switch on p21(ras): structural basis for the nitric oxide-p21(ras) interaction. J. Biol. Chem. 272:1997;4323-4326
16. ras as a common signaling target of reactive free radicals and cellular redox stress. J. Biol. Chem. 270:1995;21195-21198
17. Adachi T., Pimentel D.R., Heibeck T., Hou X., Lee Y.J., Jiang B., Ido Y., Cohen R.A. S-glutathiolation of Ras mediates redox-sensitive signaling by angiotensin II in vascular smooth muscle cells. J. Biol. Chem. 2004;. in press
18. Deora A.A., Win T., Vanhaesebroeck B., Lander H.M. A redox-triggered ras-effector interaction: recruitment of phosphatidylinositol 3′-kinase to Ras by redox stress. J. Biol. Chem. 273:1998;29923-29928
19. Thomas P., Khokha R., Shepherd F.A., Feld R., Tsao M.S. Differential expression of matrix metalloproteinases and their inhibitors in non-small cell lung cancer. J. Pathol. 190:2000;150-156
20. Kurata H., Thant A.A., Matsuo S., Senga T., Okazaki K., Hotta N., Hamaguchi M. Constitutive activation of MAP kinase kinase (MEK1) is critical and sufficient for the activation of MMP-2. Exp. Cell Res. 254:2000;180-188
21. Chiu C., Maddock D.A., Zhang Q., Souza K.P., Townsend A.R., Wan Y. TGF-beta-induced p38 activation is mediated by Rac1-regulated generation of reactive oxygen species in cultured human keratinocytes. Int. J. Mol. Med. 8:2001;251-255
22. 2-induced apoptosis in bovine aortic endothelial cells. Acta Pharmacol. Sin. 21:2000;41-45
23. Robinson C.J., Sloss C.M., Plevin R. Inactivation of JNK activity by mitogen-activated protein kinase phosphatase-2 in EAhy926 endothelial cells is dependent upon agonist-specific JNK translocation to the nucleus. Cell Signal. 13:2001;29-41
24. Chae H.J., Kim H.R., Kwak Y.G., Ko J.K., Joo C.U., Chae S.W. Signal transduction of nitric oxide donor-induced protection in hydrogen peroxide-mediated apoptosis in H9C2 cardiomyoblasts. Immunopharmacol. Immunotoxicol. 23:2001;187-204
25. 2-induced activation of SAPK/JNK but not for that of p38 and ERK in Chinese hamster V79 cells. Antioxid. Redox Signal. 1:1999;501-508
26. Midwinter R.G., Vissers M.C., Winterbourn C.C. Hypochlorous acid stimulation of the mitogen-activated protein kinase pathway enhances cell survival. Arch. Biochem. Biophys. 394:2001;13-20
27. Nishida M., Maruyama Y., Tanaka R., Kontani K., Nagao T., Kurose H. G alpha(i) and G alpha(o) are target proteins of reactive oxygen species. Nature. 408:2000;492-495
28. 2-induced apoptotic cell death via ERK activation. J. Neurochem. 76:2001;910-918
29. Kuruganti P.A., Wurster R.D., Lucchesi P.A. Mitogen activated protein kinase activation and oxidant signaling in astrocytoma cells. J. Neurooncol. 56:2002;109-117
30. 2-induced Erk and Src kinase activity in human neuroblastoma cells. Neuroreport. 13:2002;1057-1061
31. Frank G.D., Eguchi S., Yamakawa T., Tanaka S., Inagami T., Motley E.D. Involvement of reactive oxygen species in the activation of tyrosine kinase and extracellular signal-regulated kinase by angiotensin II. Endocrinology. 141:2000;3120-3126
32. Chiarugi P., Pani G., Giannoni E., Taddei L., Colavitti R., Raugei G., Symons M., Borrello S., Galeotti T., Ramponi G. Reactive oxygen species as essential mediators of cell adhesion: the oxidative inhibition of a FAK tyrosine phosphatase is required for cell adhesion. J. Cell Biol. 161:2003;933-944
33. 2+ in TGF-beta 1-induced IL-6 expression. J. Immunol. 165:2000;2190-2197
34. Nishinaka T., Yabe-Nishimura C. EGF receptor-ERK pathway is the major signaling pathway that mediates upregulation of aldose reductase expression under oxidative stress. Free Radic. Biol. Med. 31:2001;205-216
35. 2 is required for UVB-induced EGF receptor and downstream signaling pathway activation. Free Radic. Biol. Med. 27:1999;1197-1202
36. 2 by catalase inhibits the proliferation of HER-2/Neu-transformed rat-1 fibroblasts through the induction of a stress response. J. Biol. Chem. 276:2001;9558-9564
37. 2-induced apoptosis in bovine aortic endothelial cells. Acta Pharmacol. Sin. 21:2000;991-996
38. Han M.J., Kim B.Y., Yoon S.O., Chung A.S. Cell proliferation induced by reactive oxygen species is mediated via mitogen-activated protein kinase in Chinese hamster lung fibroblast (V79) cells. Mol. Cells. 15:2003;94-101
39. O'Donnell E., Vereker E., Lynch M.A. Age-related impairment in LTP is accompanied by enhanced activity of stress-activated protein kinases: analysis of underlying mechanisms. Eur. J. Neurosci. 12:2000;345-352
40. Ishikawa Y., Kitamura M. Anti-apoptotic effect of quercetin: intervention in the JNK- and ERK-mediated apoptotic pathways. Kidney Int. 58:2000;1078-1087
41. Ding M., Li J., Leonard S.S., Shi X., Costa M., Castranova V., Vallyathan V., Huang C. Differential role of hydrogen peroxide in UV-induced signal transduction. Mol. Cell. Biochem. 234-235:2002;81-90
42. Cuda G., Paterno R., Ceravolo R., Candigliota M., Perrotti N., Perticone F., Faniello M.C., Schepis F., Ruocco A., Mele E., Cassano S., Bifulco M., Santillo M., Avvedimento E.V. Protection of human endothelial cells from oxidative stress: role of Ras-ERK1/2 signaling. Circulation. 105:2002;968-974
43. Banno Y., Wang S., Ito Y., Izumi T., Nakashima S., Shimizu T., Nozawa Y. Involvement of ERK and p38 MAP kinase in oxidative stress-induced phospholipase D activation in PC12 cells. Neuroreport. 12:2001;2271-2275
44. Frost J.A., Geppert T.D., Cobb M.H., Feramisco J.R. A requirement for extracellular signal-regulated kinase (ERK) function in the activation of AP-1 by Ha-Ras, phorbol 12-myristate 13-acetate, and serum. Proc. Natl. Acad. Sci. USA. 91:1994;3844-3848
45. Westermarck J., Kahari V.M. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J. 13:1999;781-792
46. Chiarugi P., Cirri P. Redox regulation of protein tyrosine phosphatases during receptor tyrosine kinase signal transduction. Trends Biochem. Sci. 28:2003;509-514
47. Brenneisen P., Wenk J., Wlaschek M., Krieg T., Scharffetter-Kochanek K. Activation of p70 ribosomal protein S6 kinase is an essential step in the DNA damage-dependent signaling pathway responsible for the ultraviolet B-mediated increase in interstitial collagenase (MMP-1) and stromelysin-1 (MMP-3) protein levels in human dermal fibroblasts. J. Biol. Chem. 275:2000;4336-4344
48. Allen R.G., Tresini M. Oxidative stress and gene regulation. Free Radic. Biol. Med. 28:2000;463-499
49. Han Z., Boyle D.L., Chang L., Bennett B., Karin M., Yang L., Manning A.M., Firestein G.S. c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J. Clin. Invest. 108:2001;73-81
50. Yang S.H., Sharrocks A.D., Whitmarsh A.J. Transcriptional regulation by the MAP kinase signaling cascades. Gene. 320:2003;3-21
51. Reddy S.P., Mossman B.T. Role and regulation of activator protein-1 in toxicant-induced responses of the lung. Am. J. Physiol. Lung Cell Mol. Physiol. 283:2002;L1161-L1178
52. 2 and tumor necrosis factor-alpha activate intercellular adhesion molecule 1 (ICAM-1) gene transcription through distinct cis-regulatory elements within the ICAM-1 promoter. J. Biol. Chem. 270:1995;18966-18974
53. Wasylyk B., Hahn S.L., Giovane A. The Ets family of transcription factors. Eur. J. Biochem. 211:1993;7-18
54. Woessner J.F. Jr. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 5:1991;2145-2154
55. Rabault B., Roussel M.F., Quang C.T., Ghysdael J. Phosphorylation of Ets1 regulates the complementation of a CSF-1 receptor impaired in mitogenesis. Oncogene. 13:1996;877-881
56. Rutter J.L., Mitchell T.I., Buttice G., Meyers J., Gusella J.F., Ozelius L.J., Brinckerhoff C.E. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res. 58:1998;5321-5325
57. Yasuda M., Ohzeki Y., Shimizu S., Naito S., Ohtsuru A., Yamamoto T., Kuroiwa Y. Stimulation of in vitro angiogenesis by hydrogen peroxide and the relation with ETS-1 in endothelial cells. Life Sci. 64:1999;249-258
58. Sanij E., Hatzistavrou T., Hertzog P., Kola I., Wolvetang E.J. Ets-2 is induced by oxidative stress and sensitizes cells to H(2)O(2)-induced apoptosis: implications for Down's syndrome. Biochem. Biophys. Res. Commun. 287:2001;1003-1008
59. Westermarck J., Kahari V.M. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J. 13:1999;781-792
60. Fu X., Kassim S.Y., Parks W.C., Heinecke J.W. Hypochlorous acid oxygenates the cysteine switch domain of pro-matrilysin (MMP-7): a mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase. J. Biol. Chem. 276:2001;41279-41287
61. Rajagopalan S., Meng X.P., Ramasamy S., Harrison D.G., Galis Z.S. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro: implications for atherosclerotic plaque stability. J. Clin. Invest. 98:1996;2572-2579
62. Saari H., Sorsa T., Lindy O., Suomalainen K., Halinen S., Konttinen Y.T. Reactive oxygen species as regulators of human neutrophil and fibroblast interstitial collagenases. Int. J. Tissue React. 14:1992;113-120
63. 2 exposure. Lab Invest. 77:1997;533-539
64. Galis Z.S., Khatri J.J. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ. Res. 90:2002;251-262
65. Zhang H.J., Zhao W., Venkataraman S., Robbins M.E., Buettner G.R., Kregel K.C., Oberley L.W. Activation of matrix metalloproteinase-2 by overexpression of manganese superoxide dismutase in human breast cancer MCF-7 cells involves reactive oxygen species. J. Biol. Chem. 277:2002;20919-20926
66. Meli D.N., Christen S., Leib S.L. Matrix metalloproteinase-9 in pneumococcal meningitis: activation via an oxidative pathway. J. Infect. Dis. 187:2003;1411-1415
67. Wert S.E., Yoshida M., LeVine M., Ikegami M., Jones T., Ross G.F., Fisher J.H., Korfhagen T.R., Whitsett J.A. Increased metalloproteinase activity, oxidant production, and emphysema in surfactant protein D gene-inactivated mice. Proc. Natl. Acad. Sci. USA. 97:2000;5972-5977
68. 2 activates pro-matrix metalloproteinase-2 through receptor tyrosine kinases/phosphatidylinositol 3-kinase/NF-kappa B pathway. J. Biol. Chem. 277:2002;30271-30282
69. Zhang Z., Oliver P., Lancaster J.R. Jr., Schwarzenberger P.O., Joshi M.S., Cork J., Kolls J.K. Reactive oxygen species mediate tumor necrosis factor alpha-converting, enzyme-dependent ectodomain shedding induced by phorbol myristate acetate. FASEB J. 15:2001;303-305
70. Borutaite V., Brown G.C. Caspases are reversibly inactivated by hydrogen peroxide. FEBS Lett. 500:2001;114-118
71. Inoue N., Takeshita S., Gao D., Ishida T., Kawashima S., Akita H., Tawa R., Sakurai H., Yokoyama M. Lysophosphatidylcholine increases the secretion of matrix metalloproteinase 2 through the activation of NADH/NADPH oxidase in cultured aortic endothelial cells. Atherosclerosis. 155:2001;45-52
72. 2-dependent ERK1,2 activation. J. Biol. Chem. 276:2001;14264-14270
73. Wenk J., Brenneisen P., Wlaschek M., Poswig A., Briviba K., Oberley T.D., Scharffetter-Kochanek K. Stable overexpression of manganese superoxide dismutase in mitochondria identifies hydrogen peroxide as a major oxidant in the AP-1-mediated induction of matrix-degrading metalloprotease-1. J. Biol. Chem. 274:1999;25869-25876
74. Kheradmand F., Werner E., Tremble P., Symons M., Werb Z. Role of Rac1 and oxygen radicals in collagenase-1 expression induced by cell shape change. Science. 280:1998;898-902
75. Fisher G.J., Wang Z.Q., Datta S.C., Varani J., Kang S., Voorhees J.J. Pathophysiology of premature skin aging induced by ultraviolet light. N. Engl. J. Med. 337:1997;1419-1428
76. Fisher G.J., Datta S.C., Talwar H.S., Wang Z.Q., Varani J., Kang S., Voorhees J.J. Molecular basis of sun-induced premature skin ageing and retinoid antagonism. Nature. 379:1996;335-339
77. Manzano V.M., Puyol M.R., Puyol D.R., Cazana F.J. Tretinoin prevents age-related renal changes and stimulates antioxidant defenses in cultured renal mesangial cells. J. Pharmacol. Exp. Ther. 289:1999;123-132
78. Brennan M., Bhatti H., Nerusu K.C., Bhagavathula N., Kang S., Fisher G.J., Varani J., Voorhees J.J. Matrix metalloproteinase-1 is the major collagenolytic enzyme responsible for collagen damage in UV-irradiated human skin. Photochem. Photobiol. 78:2003;43-48
79. Yin L., Yamauchi R., Tsuji T., Krutmann J., Morita A. The expression of matrix metalloproteinase-1 mRNA induced by ultraviolet A1 (340-400 nm) is phototherapy relevant to the glutathione (GSH) content in skin fibroblasts of systemic sclerosis. J. Dermatol. 30:2003;173-180
80. Offord E.A., Gautier J.C., Avanti O., Scaletta C., Runge F., Kramer K., Applegate L.A. Photoprotective potential of lycopene, β-carotene, vitamin E, vitamin C and carnosic acid in UVA-irradiated human skin fibroblasts. Free Radic. Biol. Med. 32:2002;1293-1303
81. Wood G.A., Archer M.C. Matrix metalloproteinases-2 and 9 do not play a role in the growth of preneoplastic liver lesions in F344 rats. Exp. Biol. Med. 226:2001;799-803
82. Upadhya G.A., Strasberg S.M. Glutathione, lactobionate, and histidine: cryptic inhibitors of matrix metalloproteinases contained in University of Wisconsin and histidine/tryptophan/ketoglutarate liver preservation solutions. Hepatology. 31:2000;1115-1122
83. Tyagi S.C., Kumar S., Borders S. Reduction-oxidation (redox) state regulation of extracellular matrix metalloproteinases and tissue inhibitors in cardiac normal and transformed fibroblast cells. J. Cell. Biochem. 61:1996;139-151
84. 2+ ATPase by tertiary butylhydroperoxide. Mol. Cell. Biochem. 237:2002;85-93
85. Nozoe T., Honda M., Inutsuka S., Yasuda M., Korenaga D. Significance of immunohistochemical expression of manganese superoxide dismutase as a marker of malignant potential in colorectal carcinoma. Oncol. Rep. 10:2003;39-43
86. Thomas F.H., Leask R., Srsen V., Riley S.C., Spears N., Telfer E.E. Effect of ascorbic acid on health and morphology of bovine preantral follicles during long-term culture. Reproduction. 122:2001;487-495
87. Godichaud S., Krisa S., Couronne B., Dubuisson L., Merillon J.M., Desmouliere A., Rosenbaum J. Deactivation of cultured human liver myofibroblasts by trans-resveratrol, a grapevine-derived polyphenol. Hepatology. 31:2000;922-931
88. Hozumi A., Nishimura Y., Nishiuma T., Kotani Y., Yokoyama M. Induction of MMP-9 in normal human bronchial epithelial cells by TNF-alpha via NF-kappa B-mediated pathway. Am. J. Physiol. Lung Cell Mol. Physiol. 281:2001;L1444-L1452
89. Uemura S., Matsushita H., Li W., Glassford A.J., Asagami T., Lee K.H., Harrison D.G., Tsao P.S. Diabetes mellitus enhances vascular matrix metalloproteinase activity: role of oxidative stress. Circ. Res. 88:2001;1291-1298
90. Buhimschi I.A., Kramer W.B., Buhimschi C.S., Thompson L.P., Weiner C.P. Reduction-oxidation (redox) state regulation of matrix metalloproteinase activity in human fetal membranes. Am. J. Obstet. Gynecol. 182:2000;458-464
91. Yoshida M., Korfhagen T.R., Whitsett J.A. Surfactant protein D regulates NF-kappa B and matrix metalloproteinase production in alveolar macrophages via oxidant-sensitive pathways. J. Immunol. 166:2001;7514-7519
92. Siwik D.A., Pagano P.J., Colucci W.S. Oxidative stress regulates collagen synthesis and matrix metalloproteinase activity in cardiac fibroblasts. Am. J. Physiol. Cell Physiol. 280:2001;C53-C60
93. Warner R.L., Bless N.M., Lewis C.S., Younkin E., Beltran L., Guo R., Johnson K.J., Varani J. Time-dependent inhibition of immune complex-induced lung injury by catalase: relationship to alterations in macrophage and neutrophil matrix metalloproteinase elaboration. Free Radic. Biol. Med. 29:2000;8-16
94. Ishii Y., Ogura T., Tatemichi M., Fujisawa H., Otsuka F., Esumi H. Induction of matrix metalloproteinase gene transcription by nitric oxide and mechanisms of MMP-1 gene induction in human melanoma cell lines. Int. J. Cancer. 103:2003;161-168
95. Harmey J.H., Bucana C.D., Lu W., Byrne A.M., McDonnell S., Lynch C., Bouchier-Hayes D., Dong Z. Lipopolysaccharide-induced metastatic growth is associated with increased angiogenesis, vascular permeability and tumor cell invasion. Int. J. Cancer. 101:2002;415-422
96. Zaragoza C., Soria E., Lopez E., Browning D., Balbin M., Lopez-Otin C., Lamas S. Activation of the mitogen activated protein kinase extracellular signal-regulated kinase 1 and 2 by the nitric oxide-cGMP-cGMP-dependent protein kinase axis regulates the expression of matrix metalloproteinase 13 in vascular endothelial cells. Mol. Pharmacol. 62:2002;927-935
97. Franchi A., Santucci M., Masini E., Sardi I., Paglierani M., Gallo O. Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck. Cancer. 95:2002;1902-1910
98. Lin S.K., Kok S.H., Kuo M.Y., Lee M.S., Wang C.C., Lan W.H., Hsiao M., Goldring S.R., Hong C.Y. Nitric oxide promotes infectious bone resorption by enhancing cytokine-stimulated interstitial collagenase synthesis in osteoblasts. J. Bone Miner. Res. 18:2003;39-46
99. Novaro V., Colman-Lerner A., Ortega F.V., Jawerbaum A., Paz D., Lo N.F., Pustovrh C., Gimeno M.F., Gonzalez E. Regulation of metalloproteinases by nitric oxide in human trophoblast cells in culture. Reprod. Fertil. Dev. 13:2001;411-420
100. Pustovrh C., Jawerbaum A., Sinner D., Pesaresi M., Baier M., Micone P., Gimeno M., Gonzalez E.T. Membrane-type matrix metalloproteinase-9 activity in placental tissue from patients with pre-existing and gestational diabetes mellitus. Reprod. Fertil. Dev. 12:2000;269-275
101. Gu Z., Kaul M., Yan B., Kridel S.J., Cui J., Strongin A., Smith J.W., Liddington R.C., Lipton S.A. S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death. Science. 297:2002;1186-1190
102. Mayers I., Hurst T., Puttagunta L., Radomski A., Mycyk T., Sawicki G., Johnson D., Radomski M.W. Cardiac surgery increases the activity of matrix metalloproteinases and nitric oxide synthase in human hearts. J. Thoracic Cardiovasc. Surg. 122:2001;746-752
103. Nakatsuka M., Asagiri K., Noguchi S., Habara T., Kudo T. Nafamostat mesilate, a serine protease inhibitor, suppresses lipopolysaccharide-induced nitric oxide synthesis and apoptosis in cultured human trophoblasts. Life Sci. 67:2000;1243-1250
104. Radomski A., Jurasz P., Sanders E.J., Overall C.M., Bigg H.F., Edwards D.R., Radomski M.W. Identification, regulation and role of tissue inhibitor of metalloproteinases-4 (TIMP-4) in human platelets. Br. J. Pharmacol. 137:2002;1330-1338
105. Gao C.Q., Sawicki G., Suarez-Pinzon W.L., Csont T., Wozniak M., Ferdinandy P., Schulz R. Matrix metalloproteinase-2 mediates cytokine-induced myocardial contractile dysfunction. Cardiovasc. Res. 57:2003;426-433
106. Eberhardt W., Beeg T., Beck K.F., Walpen S., Gauer S., Bohles H., Pfeilschifter J. Nitric oxide modulates expression of matrix metalloproteinase-9 in rat mesangial cells. Kidney Int. 57:2000;59-69
107. Gurjar M.V., Sharma R.V., Bhalla R.C. eNOS gene transfer inhibits smooth muscle cell migration and MMP-2 and MMP-9 activity. Arterioscler. Thromb. Vasc. Biol. 19:1999;2871-2877
108. Jurasz P., Sawicki G., Duszyk M., Sawicka J., Miranda C., Mayers I., Radomski M.W. Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide. Cancer Res. 61:2001;376-382
109. Matsunaga T., Weihrauch D.W., Moniz M.C., Tessmer J., Warltier D.C., Chilian W.M. Angiostatin inhibits coronary angiogenesis during impaired production of nitric oxide. Circulation. 105:2002;2185-2191
110. Eagleton M.J., Peterson D.A., Sullivan V.V., Roelofs K.J., Ford J.A., Stanley J.C., Upchurch G.R. Jr. Nitric oxide inhibition increases aortic wall matrix metalloproteinase-9 expression. J. Surg. Res. 104:2002;15-21
111. Owens M.W., Milligan S.A., Jourd'heuil D., Grisham M.B. Effects of reactive metabolites of oxygen and nitrogen on gelatinase A activity. Am. J. Physiol. 273:1997;L445-L450
112. Okamoto T., Akaike T., Sawa T., Miyamoto Y., van D.V., Maeda H. Activation of matrix metalloproteinases by peroxynitrite-induced protein S-glutathiolation via disulfide S-oxide formation. J. Biol. Chem. 276:2001;29596-29602
113. Okamoto T., Akaike T., Nagano T., Miyajima S., Suga M., Ando M., Ichimori K., Maeda H. Activation of human neutrophil procollagenase by nitrogen dioxide and peroxynitrite: a novel mechanism for procollagenase activation involving nitric oxide. Arch. Biochem. Biophys. 342:1997;261-274
114. Khorramizadeh M.R., Tredget E.E., Telasky C., Shen Q., Ghahary A. Aging differentially modulates the expression of collagen and collagenase in dermal fibroblasts. Mol. Cell. Biochem. 194:1999;99-108
115. Kumar S., Millis A.J., Baglioni C. Expression of interleukin 1-inducible genes and production of interleukin 1 by aging human fibroblasts. Proc. Natl. Acad. Sci. USA. 89:1992;4683-4687
116. Mori Y., Hatamochi A., Arakawa M., Ueki H. Reduced expression of mRNA for transforming growth factor beta (TGF beta) and TGF beta receptors I and II and decreased TGF beta binding to the receptors in in vitro-aged fibroblasts. Arch. Dermatol. Res. 290:1998;158-162
117. Zeng G., McCue H.M., Mastrangelo L., Millis A.J. Endogenous TGF-beta activity is modified during cellular aging: effects on metalloproteinase and TIMP-1 expression. Exp. Cell Res. 228:1996;271-276
118. Jarisch A., Krieg T., Hunzelmann N. Regulation of collagen expression by interleukin-1 beta is dependent on donor age. Acta Dermatol. Venereol. 76:1996;287-290
119. Edwards D.R., Leco K.J., Beaudry P.P., Atadja P.W., Veillette C., Riabowol K.T. Differential effects of transforming growth factor-beta 1 on the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in young and old human fibroblasts. Exp. Gerontol. 31:1996;207-223
120. Millis A.J., Hoyle M., McCue H.M., Martini H. Differential expression of metalloproteinase and tissue inhibitor of metalloproteinase genes in aged human fibroblasts. Exp. Cell Res. 201:1992;373-379
121. Llorente L., Richaud-Patin Y., Diaz-Borjon A., Jakez-Ocampo J., Alvarado-DeLa Barrera C. Increased collagenase and dipeptidyl peptidase I activity in leucocytes from healthy elderly people. Clin. Exp. Immunol. 116:1999;425-429
122. Ashcroft G.S., Horan M.A., Herrick S.E., Tarnuzzer R.W., Schultz G.S., Ferguson M.W. Age-related differences in the temporal and spatial regulation of matrix metalloproteinases (MMPs) in normal skin and acute cutaneous wounds of healthy humans. Cell Tissue Res. 290:1997;581-591
123. Liu J., Roughley P.J., Mort J.S. Identification of human intervertebral disc stromelysin and its involvement in matrix degradation. J. Orthop. Res. 9:1991;568-575
124. West M.D., Pereira-Smith O.M., Smith J.R. Replicative senescence of human skin fibroblasts correlates with a loss of regulation and overexpression of collagenase activity. Exp. Cell Res. 184:1989;138-147
125. Chen Y.Q., Mauviel A., Ryynanen J., Sollberg S., Uitto J. Type VII collagen gene expression by human skin fibroblasts and keratinocytes in culture: influence of donor age and cytokine responses. J. Invest. Dermatol. 102:1994;205-209
126. Miyazaki M., Gohda E., Kaji K., Namba M. Increased hepatocyte growth factor production by aging human fibroblasts mainly due to autocrine stimulation by interleukin-1. Biochem. Biophys. Res. Commun. 246:1998;255-260
127. Cannon J.G., Fiatarone M.A., Meydani M., Gong J., Scott L., Blumberg J.B., Evans W.J. Aging and dietary modulation of elastase and interleukin-1 beta secretion. Am. J. Physiol. 268:1995;R208-R213
128. Liao Z., Tu J.H., Small C.B., Schnipper S.M., Rosenstreich D.L. Increased urine interleukin-1 levels in aging. Gerontology. 39:1993;19-27
129. Werner E., Werb Z. Integrins engage mitochondrial function for signal transduction by a mechanism dependent on Rho GTPases. J. Cell Biol. 158:2002;357-368
130. Wlaschek M., Heinen G., Poswig A., Schwarz A., Krieg T., Scharffetter-Kochanek K. UVA-induced autocrine stimulation of fibroblast-derived collagenase/MMP-1 by interrelated loops of interleukin-1 and interleukin-6. Photochem. Photobiol. 59:1994;550-556
131. Brenneisen P., Sies H., Scharffetter-Kochanek K. Ultraviolet-B irradiation and matrix metalloproteinases: from induction via signaling to initial events. Ann. N.Y. Acad. Sci. 973:2002;31-43
132. Day B.J., Melov S., Wallace D.C., Crapo J.D. Development of an interstitial fibrosis phenotype in aged SOD2 heterozygous KO mice. Free Radic. Biol. Med. 27:1999;S59
133. Wong G.H.W., Goeddel D.V. Induction of manganous superoxide dismutase by tumor necrosis factor: possible protective mechanism. Science. 242:1988;941-944
134. Visner G.A., Dougall W.C., Wilson J.M., Burr I.A., Nick H.S. Regulation of manganese superoxide dismutase by lipopolysaccharide interleukin-1 and tumor necrosis factor. J. Biol. Chem. 265:1990;2856-2864
135. West-Mays J.A., Strissel K.J., Sadow P.M., Fini M.E. Competence for collagenase gene expression by tissue fibroblasts requires activation of an interleukin 1 alpha autocrine loop. Proc. Natl. Acad. Sci. USA. 92:1995;6768-6772
136. Poswig A., Wenk J., Brenneisen P., Wlaschek M., Hommel C., Quel G., Faisst K., Dissemond J., Briviba K., Krieg T., Scharffetter-Kochanek K. Adaptive antioxidant response of manganese-superoxide dismutase following repetitive UVA irradiation. J. Invest. Dermatol. 112:1999;13-18
137. Sasaki H., Akamatsu H., Horio T. Effects of a single exposure to UVB radiation on the activities and protein levels of copper-zinc and manganese superoxide dismutase in cultured human keratinocytes. Photochem. Photobiol. 65:1997;707-713
138. Fujii J., Taniguchi N. Phorbol ester induces manganese-superoxide dismutase in tumor necrosis factor-resistant cells. J. Biol. Chem. 266:1991;23142-23146
139. Nelson A.R., Fingleton B., Rothenberg M.L., Matrisian L.M. Matrix metalloproteinases: biologic activity and clinical implications. J. Clin. Oncol. 18:2000;1135-1149
140. Zhang H.J., Zhao W., Venkataraman S., Robbins M.E., Buettner G.R., Kregel K.C., Oberley L.W. Activation of matrix metalloproteinase-2 by overexpression of manganese superoxide dismutase in human breast cancer MCF-7 cells involves reactive oxygen species. J. Biol. Chem. 277:2002;20919-20926
141. Curran S., Murray G.I. Matrix metalloproteinases in tumour invasion and metastasis. J. Pathol. 189:1999;300-308
142. Ito T., Ito M., Shiozawa J., Naito S., Kanematsu T., Sekine I. Expression of the MMP-1 in human pancreatic carcinoma: relationship with prognostic factor. Mod. Pathol. 12:1999;669-674
143. Mizutani K., Kofuji K., Shirouzu K. The significance of MMP-1 and MMP-2 in peritoneal disseminated metastasis of gastric cancer. Surg. Today. 30:2000;614-621
144. Shiozawa J., Ito M., Nakayama T., Nakashima M., Kohno S., Sekine I. Expression of matrix metalloproteinase-1 in human colorectal carcinoma. Mod. Pathol. 13:2000;925-933
145. Murray G.I., Duncan M.E., O'Neil P., Melvin W.T., Fothergill J.E. Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nat. Med. 2:1996;461-462
146. Murray G.I., Duncan M.E., Arbuckle E., Melvin W.T., Fothergill J.E. Matrix metalloproteinases and their inhibitors in gastric cancer. Gut. 43:1998;791-797
147. Remacle A.G., Noel A., Duggan C., McDermott E., O'Higgins N., Foidart J.M., Duffy M.J. Assay of matrix metalloproteinases types 1, 2, 3 and 9 in breast cancer. Br. J. Cancer. 77:1998;926-931
148. Jung K., Nowak L., Lein M., Priem F., Schnorr D., Loening S.A. Matrix metalloproteinases 1 and 3, tissue inhibitor of metalloproteinase-1 and the
149. Johansson N., Airola K., Grenman R., Kariniemi A.L., Saarialho-Kere U., Kahari V.M. Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck. Am. J. Pathol. 151:1997;499-508
150. Onisto M., Garbisa S., Caenazzo C., Freda M.P., Di Francesco C., Nitti D., Liotta L.A., Stetler-Stevenson W.G. Reverse transcription-polymerase chain reaction phenotyping of metalloproteinases and inhibitors involved in tumor matrix invasion. Diagn. Mol. Pathol. 2:1993;74-80
151. Bolon I., Gouyer V., Devouassoux M., Vandenbunder B., Wernert N., Moro D., Brambilla C., Brambilla E. Expression of c-ets-1, collagenase 1, and urokinase-type plasminogen activator genes in lung carcinomas. Am. J. Pathol. 147:1995;1298-1310
152. Murray G.I., Duncan M.E., O'Neil P., McKay J.A., Melvin W.T., Fothergill J.E. Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer. J. Pathol. 185:1998;256-261
153. Kanamori Y., Matsushima M., Minaguchi T., Kobayashi K., Sagae S., Kudo R., Terakawa N., Nakamura Y. Correlation between expression of the matrix metalloproteinase-1 gene in ovarian cancers and an insertion/deletion polymorphism in its promoter region. Cancer Res. 59:1999;4225-4227
154. Ye S., Dhillon S., Turner S.J., Bateman A.C., Theaker J.M., Pickering R.M., Day I., Howell W.M. Invasiveness of cutaneous malignant melanoma is influenced by matrix metalloproteinase 1 gene polymorphism. Cancer Res. 61:2001;1296-1298
155. Noll W.W., Belloni D.R., Rutter J.L., Storm C.A., Schned A.R., Titus-Ernstoff L., Ernstoff M.S., Brinckerhoff C.E. Loss of heterozygosity on chromosome 11q22-23 in melanoma is associated with retention of the insertion polymorphism in the matrix metalloproteinase-1 promoter. Am. J. Pathol. 158:2001;691-697
156. Zhu Y., Spitz M.R., Lei L., Mills G.B., Wu X. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility. Cancer Res. 61:2001;7825-7829
157. Hirata H., Naito K., Yoshihiro S., Matsuyama H., Suehiro Y., Hinoda Y. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter is associated with conventional renal cell carcinoma. Int. J. Cancer. 106:2003;372-374
158. Hinoda Y., Okayama N., Takano N., Fujimura K., Suehiro Y., Hamanaka Y., Hazama S., Kitamura Y., Kamatani N., Oka M. Association of functional polymorphisms of matrix metalloproteinase (MMP)-1 and MMP-3 genes with colorectal cancer. Int. J. Cancer. 102:2002;526-529
159. Ghilardi G., Biondi M.L., Mangoni J., Leviti S., DeMonti M., Guagnellini E., Scorza R. Matrix metalloproteinase-1 promoter polymorphism 1G/2G is correlated with colorectal cancer invasiveness. Clin. Cancer Res. 7:2001;2344-2346
160. Nishioka Y., Kobayashi K., Sagae S., Ishioka S., Nishikawa A., Matsushima M., Kanamori Y., Minaguchi T., Nakamura Y., Tokino T., Kudo R. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter in endometrial carcinomas. Jpn. J. Cancer Res. 91:2000;612-615
161. Brinckerhoff C.E., Rutter J.L., Benbow U. Interstitial collagenases as markers of tumor progression. Clin. Cancer Res. 6:2000;4823-4830
162. Janssen A.M., Bosman C.B., van Duijn W., Oostendorp-van de Ruit M.M., Kubben F.J., Griffioen G., Lamers C.B., van Krieken J.H., van de Velde C.J., Verspaget H.W. Superoxide dismutases in gastric and esophageal cancer and the prognostic impact in gastric cancer. Clin. Cancer Res. 6:2000;3183-3192
163. Janssen A.M., Bosman C.B., Sier C.F., Griffioen G., Kubben F.J., Lamers C.B., van Krieken J.H., van de Velde C.J., Verspaget H.W. Superoxide dismutases in relation to the overall survival of colorectal cancer patients. Br. J. Cancer. 78:1998;1051-1057
164. Toh Y., Kuninaka S., Oshiro T., Ikeda Y., Nakashima H., Baba H., Kohnoe S., Okamura T., Mori M., Sugimachi K. Overexpression of manganese superoxide dismutase mRNA may correlate with aggressiveness in gastric and colorectal adenocarcinomas. Int. J. Oncol. 17:2000;107-112
165. Satomi A., Murakami S., Hashimoto T., Ishida K., Matsuki M., Sonoda M. Significance of superoxide dismutase (SOD) in human colorectal cancer tissue: correlation with malignant intensity. J. Gastroenterol. 30:1995;177-182
166. Malafa M., Margenthaler J., Webb B., Neitzel L., Christophersen M. MnSOD expression is increased in metastatic gastric cancer. J. Surg. Res. 88:2000;130-134
167. Li N., Oberley T.D., Oberley L.W., Zhong W. Overexpression of manganese superoxide dismutase in DU145 human prostate carcinoma cells has multiple effects on cell phenotype. Prostate. 35:1998;221-233
168. Li N., Oberley T.D., Oberley L.W., Zhong W. Inhibition of cell growth in NIH/3T3 fibroblasts by overexpression of manganese superoxide dismutase: mechanistic studies. J. Cell. Physiol. 175:1998;359-369
169. 2. Free Radic. Biol. Med. 29:2000;801-813
170. Inoue T., Yashiro M., Nishimura S., Maeda K., Sawada T., Ogawa Y., Sowa M., Chung K.H. Matrix metalloproteinase-1 expression is a prognostic factor for patients with advanced gastric cancer. Int. J. Mol. Med. 4:1999;73-77
171. Tower G.B., Benbow U., Rutter J.L., Brinckerhoff C.E. Characterization of pathways that activate protein complexes binding to a single polymorphism in the collagenase-1 (matrix metalloproteinase-1) promoter. Proc. 91st Annual Meeting of the AACR. 41(3494):2000;549
172. Zyad A., Benard J., Tursz T., Clarke R., Chouaib S. Resistance to TNF-alpha and adriamycin in the human breast cancer MCF-7 cell line: relationship to MDR1, MnSOD, and TNF gene expression. Cancer Res. 54:1994;825-831
173. Sunami E., Tsuno N., Osada T., Saito S., Kitayama J., Tomozawa S., Tsuruo T., Shibata Y., Muto T., Nagawa H. MMP-1 is a prognostic marker for hematogenous metastasis of colorectal cancer. Oncologist. 5:2000;108-114
174. Ambrosone C.B., Freudenheim J.L., Thompson P.A., Bowman E., Vena J.E., Marshall J.R., Graham S., Laughlin R., Nemoto T., Shields P.G. Manganese superoxide dismutase (MnSOD) genetic polymorphisms, dietary antioxidants, and risk of breast cancer. Cancer Res. 59:1999;602-606
175. Masuda A., Longo D.L., Kobayashi Y., Appella E., Oppenheim J.J., Matsushima K. Induction of mitochondrial manganese superoxide dismutase by interleukin 1. FASEB J. 2:1988;3087-3091
176. 2 tolerance. Am. J. Physiol. 263:1992;L22-L26
177. Murley J.S., Kataoka Y., Weydert C.J., Oberley L.W., Grdina D.J. Delayed cytoprotection after enhancement of Sod2 (MnSOD) gene expression in SA-NH mouse sarcoma cells exposed to WR-1065, the active metabolite of amifostine. Radiat. Res. 158:2002;101-109
178. Lavrovsky Y., Chatterjee B., Clark R.A., Roy A.K. Role of redox-regulated transcription factors in inflammation, aging and age-related diseases. Exp. Gerontol. 35:2000;521-532
179. Clark R.A. Activation of the neutrophil respiratory burst oxidase. J. Infect. Dis. 179(Suppl. 2):1999;S309-S317
180. Baker E.A., Bergin F.G., Leaper D.J. Matrix metalloproteinases, their tissue inhibitors and colorectal cancer staging. Br. J. Surg. 87:2000;1215-1221
181. Scully S.P., Berend K.R., Toth A., Qi W.N., Qi Z., Block J.A. Interstitial collagenase gene expression correlates with in vitro invasion in human chondrosarcoma. Clin. Orthop. 376:2000;291-303
182. Yukiue H., Sasaki H., Kobayashi Y., Nakashima Y., Moriyama S., Yano M., Kaji M., Kiriyama M., Fukai I., Yamakawa Y., Fujii Y. Clinical significance of tissue inhibitor of metalloproteinase and matrix metalloproteinase mRNA expression in thymoma. J. Surg. Res. 109:2003;86-91
183. Chen X., Kanekura T., Zhang G.Y. Expression of matrix metalloproteinases in metastatic lesions of cutaneous squamous cell carcinoma. Hunan Yi Ke Da Xue Xue Bao. 26:2001;297-300
184. Shindoh M., Higashino F., Kaya M., Yasuda M., Funaoka K., Hanzawa M., Hida K., Kohgo T., Amemiya A., Yoshida K., Fujinaga K. Correlated expression of matrix metalloproteinases and ets family transcription factor E1A-F in invasive oral squamous-cell-carcinoma-derived cell lines. Am. J. Pathol. 148:1996;693-700
185. Nagata M., Fujita H., Ida H., Hoshina H., Inoue T., Seki Y., Ohnishi M., Ohyama T., Shingaki S., Kaji M., Saku T., Takagi R. Identification of potential biomarkers of lymph node metastasis in oral squamous cell carcinoma by cDNA microarray analysis. Int. J. Cancer. 106:2003;683-689
186. Kurahara S., Shinohara M., Ikebe T., Nakamura S., Beppu M., Hiraki A., Takeuchi H., Shirasuna K. Expression of MMPS, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: correlations with tumor invasion and metastasis. Head Neck. 21:1999;627-638
187. Airola K., Karonen T., Vaalamo M., Lehti K., Lohi J., Kariniemi A.L., Keski-Oja J., Saarialho-Kere U.K. Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas. Br. J. Cancer. 80:1999;733-743
188. Nikkola J., Vihinen P., Vlaykova T., Hahka-Kemppinen M., Kahari V.M., Pyrhonen S. High collagenase-1 expression correlates with a favourable chemoimmunotherapy response in human metastatic melanoma. Melanoma Res. 11:2001;157-166
189. Fini M.E., Cook J.R., Mohan R., Brinckerhoff C.E. Regulation of matrix metalloproteinase gene expression. Parks W.C., Mecham R.P. Matrix metalloproteinases. 1998;299-356 Academic Press, San Diego
190. Benbow U., Schoenermark M.P., Mitchell T.I., Rutter J.L., Shimokawa K., Nagase H., Brinckerhoff C.E. A novel host/tumor cell interaction activates matrix metalloproteinase 1 and mediates invasion through type I collagen. J. Biol. Chem. 274:1999;25371-25378
191. Hart C.A., Scott L.J., Bagley S., Bryden A.A., Clarke N.W., Lang S.H. Role of proteolytic enzymes in human prostate bone metastasis formation: in vivo and in vitro studies. Br. J. Cancer. 86:2002;1136-1142
192. Benbow U., Rutter J.L., Lowrey C.H., Brinckerhoff C.E. Transcriptional repression of the human collagenase-1 (MMP-1) gene in MDA231 breast cancer cells by all-trans-retinoic acid requires distal regions of the promoter. Br. J. Cancer. 79:1999;221-228
193. Izutani R., Asano S., Imano M., Kuroda D., Kato M., Ohyanagi H. Expression of manganese superoxide dismutase in esophageal and gastric cancers. J. Gastroenterol. 33:1998;816-822
194. Kim J.J., Chae S.W., Hur G.C., Cho S.J., Kim M.K., Choi J., Nam S.Y., Kim W.H., Yang H.K., Lee B.L. Manganese superoxide dismutase expression correlates with a poor prognosis in gastric cancer. Pathobiology. 70:2002;353-360
195. Habelhah H. Induction of manganese superoxide dismutase by an immunopotentiator as a mechanism of inhibiting of malignant progression of murine tumor cells. Hokkaido Igaku Zasshi. 73:1998;519-529